Skip to main content

EDITORIAL article

Front. Physiol., 15 February 2023
Sec. Clinical and Translational Physiology
This article is part of the Research Topic Preeclampsia and the Brain: Pre-Clinical and Clinical Studies of Cerebral Involvement in Preeclampsia View all 7 articles

Editorial: Preeclampsia and the brain: Pre-clinical and clinical studies of cerebral involvement in preeclampsia

  • 1Department of Obstetrics and Gynecology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
  • 2Department of Obstetrics and Gynecology, Sahlgrenska University Hospital, Gothenburg, Sweden
  • 3Department of Women’s and Children’s Health, Uppsala University, Uppsala, Sweden
  • 4Department of Obstetrics and Gynecology, Stellenbosch University, Stellenbosch, South Africa
  • 5Vascular Physiology Laboratory, Department of Basic Sciences, Universidad del Bío-Bío, Chillán, Chile
  • 6Group of Research and Innovation in Vascular Health, GRIVAS Health, Chillan, Chile
  • 7Mercy Perinatal, Department of Obstetrics and Gynaeology, Mercy Hospital for Women, Melbourne, VIC, Australia
  • 8Department of Obstetrics and Gynaecology, Melbourne University, Melbourne, VIC, Australia
  • 9Departamento de Farmacia, Facultad de Farmacia, Universidad de Concepcion, Concepcion, Chile

Preeclampsia was first recognized as a pregnancy related condition centuries ago when women presented with cerebral complications like eclampsia. Today, eclampsia is rarely seen in high-income settings, most likely because of improved antenatal care. Preeclampsia is often diagnosed earlier in these settings and timely delivery, magnesium sulphate and blood pressure control all play a role in the decreased incidence (Chappell et al., 2021). Unfortunately, in low-to-middle-income countries this is not the case (Duley, 2009).

Cerebral complications are one of the most common causes of maternal death. Despite this, there is a paucity of research focused on the brain and preeclampsia when compared to other organs like the cardiovascular system. Recently, large register-based studies have shown that women with preeclampsia, even without eclampsia, are at increased risks of neurological disorders. These disorders include dementia, epilepsy and cognitive decline which may occur months to years after the affected pregnancy (Poon et al., 2023). Imaging studies have shown cerebral edema in up to 20% of cases of preeclampsia (Fisher et al., 2016; Fang et al., 2017). Pre-clinical and clinical studies have demonstrated blood-brain barrier impairment, cerebral blood flow alterations and increased neuroinflammatory activity but how these findings correlate to long-term neurological complications are not entirely clear (Bergman et al., 2020; Bergman et al., 2021a; Bergman et al., 2021b; Escudero et al., 2022).

There have also been reports of poorer neurological outcomes in the offspring of women with preeclampsia. These include an increased risk of cerebral palsy, stroke, developmental delays, poor cognitive development, intellectual disability, anxiety, depressive symptoms, attention-deficit disorder, and hyperactivity. The causal link between preeclampsia and these outcomes are also poorly understood (Escudero et al., 2022).

In this Research Topic, we aimed to include articles highlighting the importance of cerebral involvement in preeclampsia for mothers and their children. We have included preclinical studies with animal models of preeclampsia assessing potential pathophysiological pathways, studies of brain imaging, the analysis of potential new diagnostic biomarkers of endothelial dysfunction and a mini-review.

Two studies describe potential pathophysiological pathways to cognitive impairment following preeclampsia. Johnson et al. show that in an experimental preeclampsia rat model, persistent endothelial and smooth muscle vascular dysfunction may contribute to hippocampal dependent impairment in long-term memory. Muhammad-Jones et al. report using a preeclampsia mouse model that there is decreased neuroinflammatory response in the hippocampus. This may in be important for later hippocampal and memory function.

McBride et al. show a potential link between impaired cardiovascular function and vascular dementia. Using brain imagining they found an increase in white matter lesions, which are associated with vascular dementia, among with impaired cardiovascular function tests. Interestingly, and in contrast to previous reports, these white matter lesions were not more common in women with a history of preeclampsia.

Carlberg et al. assessed the potential of endothelial biomarkers to identify women at risk of neurological complications and other end-organ complications. They showed that thrombomodulin may be a potential biomarker to identify those at greater risk.

Whitaker et al. found impaired growth and remodeling of cerebral vessels in offspring of a preeclampsia rat model. These findings were present in both juvenile and adult offspring. This may help explain the findings of poorer neurological outcomes in children born to women with preeclampsia from register studies.

Finally, a review by Korzeniewski et al. highlighted the need for large clinical studies with long-term follow up of the child in order to implement interventions to improve long-term health for children born to women with preeclampsia.

This Research Topic aimed to serve as a platform for researchers to publish novel findings in the field of cerebral complications of preeclampsia. We hope that these articles contribute to the current understanding of cerebrovascular alterations in women with preeclampsia and their offspring and that in the near future, new strategies are developed to follow up women who have had preeclampsia and their children.

Author contributions

PV and LB created the draft. CC, CE, and RH revised the text and approved the final version.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

References

Bergman L., Acurio J., Leon J., Gatu E., Friis T., Nelander M., et al. (2020). Preeclampsia and increased permeability over the blood brain barrier - a role of vascular endothelial growth receptor 2. Am. J. Hypertens. 34, 73–81. doi:10.1093/ajh/hpaa142

CrossRef Full Text | Google Scholar

Bergman L., Cluver C., Carlberg N., Belfort M., Tolcher M. C., Panerai R. B., et al. (2021). Cerebral perfusion pressure and autoregulation in eclampsia - a case control study. Am. J. Obstet. Gynecol. 225, 185.e1–185185.e9. doi:10.1016/j.ajog.2021.03.017

PubMed Abstract | CrossRef Full Text | Google Scholar

Bergman L. H. R., Zetterberg H., Blennow K., Schell S., Langenegger E., Moodley A., et al. (2021). Evidence of neuroinflammation and blood–brain barrier disruption in women with preeclampsia and eclampsia. Cells 10, 3045. doi:10.3390/cells10113045

PubMed Abstract | CrossRef Full Text | Google Scholar

Chappell L. C., Cluver C. A., Kingdom J., Tong S. (2021). Pre-eclampsia. Lancet 398 (10297), 341–354. doi:10.1016/S0140-6736(20)32335-7

PubMed Abstract | CrossRef Full Text | Google Scholar

Duley L. (2009). The global impact of pre-eclampsia and eclampsia. Semin. Perinatol. 33 (3), 130–137. doi:10.1053/j.semperi.2009.02.010

PubMed Abstract | CrossRef Full Text | Google Scholar

Escudero C., Kupka E., Ibanez B., Sandoval H., Troncoso F., Wikstrom A. K., et al. (2022). Brain vascular dysfunction in mothers and their children exposed to preeclampsia. Hypertension 80, 242. doi:10.1161/HYPERTENSIONAHA.122.19408

PubMed Abstract | CrossRef Full Text | Google Scholar

Fang X., Liang Y., Chen D., He F., Chen J., Huang F. (2017). A study on clinicoradiological characteristics and pregnancy outcomes of reversible posterior leukoencephalopathy syndrome in preeclampsia or eclampsia. Hypertens. Res. 40 (12), 982–987. doi:10.1038/hr.2017.76

PubMed Abstract | CrossRef Full Text | Google Scholar

Fisher N., Saraf S., Egbert N., Homel P., Stein E. G., Minkoff H. (2016). Clinical correlates of posterior reversible encephalopathy syndrome in pregnancy. J. Clin. Hypertens. (Greenwich) 18 (6), 522–527. doi:10.1111/jch.12656

PubMed Abstract | CrossRef Full Text | Google Scholar

Poon L. C., Nguyen-Hoang L., Smith G. N., Bergman L., O'Brien P., Hod M., et al. (2023). Hypertensive disorders of pregnancy and long-term cardiovascular health: FIGO best practice advice. Int. J. Gynaecol. obstetrics 160 (1), 22–34. doi:10.1002/ijgo.14540

CrossRef Full Text | Google Scholar

Keywords: preeclampsia, blood brain, barrier, neuroinflammation, cognition, pre-clinical, clinical

Citation: Bergman L, Escudero CA, Cluver C, Hastie R and Torres-Vergara P (2023) Editorial: Preeclampsia and the brain: Pre-clinical and clinical studies of cerebral involvement in preeclampsia. Front. Physiol. 14:1151091. doi: 10.3389/fphys.2023.1151091

Received: 25 January 2023; Accepted: 07 February 2023;
Published: 15 February 2023.

Edited and reviewed by:

Johannes Van Lieshout, University of Amsterdam, Netherlands

Copyright © 2023 Bergman, Escudero, Cluver, Hastie and Torres-Vergara. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Lina Bergman, lina.bergman.2@gu.se

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.